BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 20677809)

  • 1. Substituted dineolignans from Magnolia garrettii.
    Schuehly W; Voith W; Teppner H; Kunert O
    J Nat Prod; 2010 Aug; 73(8):1381-4. PubMed ID: 20677809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dineolignans of 3-O-4' diphenyl ether-type from fruits of Magnolia obovata.
    Seo KH; Lee DY; Lee YG; Baek NI
    Phytochemistry; 2017 Apr; 136():133-140. PubMed ID: 28139299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of neolignans from the stem bark of Magnolia obovata on plant pathogenic fungi.
    Choi NH; Choi GJ; Min BS; Jang KS; Choi YH; Kang MS; Park MS; Choi JE; Bae BK; Kim JC
    J Appl Microbiol; 2009 Jun; 106(6):2057-63. PubMed ID: 19245403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new dimeric neolignan from Magnolia grandiflora L. seeds.
    Li HM; Zhao SR; Huo Q; Ma T; Liu H; Lee JK; Hong YS; Wu CZ
    Arch Pharm Res; 2015 Jun; 38(6):1066-71. PubMed ID: 25193624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New obovatol trimeric neolignans with NO inhibitory activity from the leaves of Magnolia officinalis var. biloba.
    Vu VT; Liu XQ; Nguyen MT; Lin YL; Kong LY; Luo JG
    Bioorg Chem; 2020 Mar; 96():103586. PubMed ID: 31982819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Constituents of the leaves of Magnolia ovata.
    Barros LF; Barison A; Salvador MJ; de Mello-Silva R; Cabral EC; Eberlin MN; Stefanello ME
    J Nat Prod; 2009 Aug; 72(8):1529-32. PubMed ID: 19658431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dibenzocyclooctadiene lignans from Magnolia and Talauma (Magnoliaceae): their absolute configuration ascertained by circular dichroism and X-ray crystallography and re-evaluation of previously published pyramidatin structures.
    Schühly W; Gröblacher B; Neyer J; Fabian WM; Fronczek FR; Kunert O
    Phytochemistry; 2010 Oct; 71(14-15):1787-95. PubMed ID: 20663528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neolignans from North American Magnolia species with cyclooxygenase 2 inhibitory activity.
    Schühly W; Khan SI; Fischer NH
    Inflammopharmacology; 2009 Apr; 17(2):106-10. PubMed ID: 19214385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A study on the relationship between tree age and bark quality in Magnolia officinalis].
    Zeng Y; Tong Z; Zhu Y; Si J; Pan X
    Zhong Yao Cai; 1999 Aug; 22(8):379-81. PubMed ID: 12571881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study on the relationship between provenance, leaf type and quality in Magnolia officinalis].
    Si J; Pan X; Tong Z; Zeng Y
    Zhong Yao Cai; 1998 Nov; 21(11):541-3. PubMed ID: 12569815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous determination of honokiol and magnolol in Magnolia officinalis by liquid chromatography with tandem mass spectrometric detection.
    Wu YT; Lin LC; Tsai TH
    Biomed Chromatogr; 2006 Oct; 20(10):1076-81. PubMed ID: 16583454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biphenyl-Type Neolignan Derivatives from the Twigs of Magnolia denudata and Their Anti-Inflammatory Activity.
    Chung CY; Kuo WL; Hwang TL; Chung MI; Chen JJ
    Chem Biodivers; 2015 Aug; 12(8):1263-70. PubMed ID: 26265578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemical constituents from the leaves of Magnolia denudata.
    Du J; Wang ML; Chen RY; Yu DQ
    J Asian Nat Prod Res; 2001; 3(4):313-9. PubMed ID: 11783585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production of honokiol and magnolol in suspension cultures of Magnolia dealbata Zucc.
    Domínguez F; Chivez M; Garduñ-Ramírez ML; Chávez-Avila VM; Mata M; Cruz-Sosa F
    Nat Prod Commun; 2009 Jul; 4(7):939-43. PubMed ID: 19731598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The relationship between the quality and the leaf shape of Magnolia officinalis produced in Hubei enshi].
    Yang HB; Shi L; Yu JJ; Li MM
    Zhong Yao Cai; 2012 Jul; 35(7):1036-9. PubMed ID: 23252263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation of anti-Saprolegnia lignans from Magnolia officinalis and SAR evaluation of honokiol/magnolol analogs.
    Hu Y; Shen Y; Tu X; Wu X; Wang GX; Ling F
    Bioorg Med Chem Lett; 2019 Feb; 29(3):389-395. PubMed ID: 30579792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioactive polar compounds from stem bark of Magnolia officinalis.
    Yu SX; Yan RY; Liang RX; Wang W; Yang B
    Fitoterapia; 2012 Mar; 83(2):356-61. PubMed ID: 22155594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obovatol isolated from Magnolia obovata enhances pentobarbital-induced sleeping time: Possible involvement of GABAA receptors/chloride channel activation.
    Ma H; Jo YJ; Ma Y; Hong JT; Kwon BM; Oh KW
    Phytomedicine; 2009 Apr; 16(4):308-13. PubMed ID: 19201178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polyethylene glycol-based ultrasound-assisted extraction of magnolol and honokiol from Cortex Magnoliae Officinalis.
    He L; Fan T; Hu J; Zhang L
    Nat Prod Res; 2015; 29(1):31-6. PubMed ID: 25204856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnolol and honokiol account for the anti-spasmodic effect of Magnolia officinalis in isolated guinea pig ileum.
    Chan SS; Zhao M; Lao L; Fong HH; Che CT
    Planta Med; 2008 Mar; 74(4):381-4. PubMed ID: 18484527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.